2 results
Approved WMOCompleted
To investigate if infarct size can be limited by introduction of IABP prior to intervention.
Approved WMOCompleted
The objective of this investigation is to describe visual outcomes and assess the safety at 12 months (330 - 420 days) post bilateral implantation of the AcrySof® IQ PanOptix* Presbyopia correcting IOL Model TFNT00.